Researchers from Seoul National University Medical Center found that ultrasound-only detected breast cancers are not very sensitive to a mammography computer-aided detection system.
Researchers from Seoul National University Medical Center found that ultrasound-only detected breast cancers are not very sensitive to a mammography computer-aided detection system.
Dr. Sang Kyu Yang and colleagues applied CAD to 96 bilateral mammograms obtained on a full-field digital system. The patient population consisted of 26 women with 29 ultrasound-detected cancers (all normal on mammography) and 70 women with 70 mammography-detected cancers. Patients in the latter group had negative findings at clinical exam.
In the ultrasound group, CAD produced 17 marks on masses and five on calcifications, correctly identifying six masses. The false-positive rate was 0.15 per image and 0.62 per case.
In the mammography group, the CAD system scored 116 marks on masses and 185 on calcifications, resulting in 58 and 139 true positives, respectively. The false-positive rate was 0.37 per image and 1.48 per case.
The sensitivity of CAD, based on radiologic primary features, was 17% for the ultrasound-detected cancers and 96% for the mammography-detected cancers. This information may be useful when applying CAD to screening mammography and adjunct ultrasound to detect early breast cancers, according to the researchers, who presented their work in a poster presentation at the 2005 RSNA meeting.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.